Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.

Abstract

Both chromosomal painting and conventional cytogenetics underestimate the cumulative dose after repeated 131I treatments. A complementary test measuring apoptosis may improve the dose estimates.